Metadata
- Name
- Open Label Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT04791514
- Description
- The main purpose of this study is to evaluate the safety and tolerability of single doses of
treprostinil palmitil inhalation powder (TPIP) in participants with pulmonary arterial
hypertension (PAH) - Data or Study Types
- clinical trial
- Keywords
- Pulmonary Arterial Hypertension, Treprostinil Palmitil Inhalation Powder, Treprostinil Palmitil
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2021
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT04791514
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT04791514